Bernhard Hoffmann
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Opus Genetics, Inc. (IRD)
Proxy statement
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Opus Genetics, Inc. (IRD) | Senior Vice President of Corporate Development | $305,000 | $789,918 |
| 2022 | Opus Genetics, Inc. (IRD) | Senior Vice President of Corporate Development | $240,000 | $446,496 |
| 2021 | Opus Genetics, Inc. (IRD) | Vice President of Corporate Development and Operations | $233,750 | $325,094 |
| 2020 | Opus Genetics, Inc. (IRD) | Vice President of Corporate Development and Operations | $36,361 | $104,179 |
| 2019 | Opus Genetics, Inc. (IRD) | Vice President of Corporate Development and Operations | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.